FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Norway For The Treatment Of Chronic Diabetic Macular Edema
July 28, 2014
Alimera Sciences To Release Second Quarter 2014 Results
July 24, 2014
Alimera Sciences' ILUVIEN® Receives Positive Outcome Of Repeat-Use Procedure For 10 Additional European Countries
June 30, 2014
Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Italy For The Treatment Of Chronic Diabetic Macular Edema
June 23, 2014
Alimera Sciences (ALIM) Files $100M Mixed Securities Shelf
August 11, 2014
Alimera Sciences, Inc. (ALIM) Posts Smaller Q2 Loss
August 07, 2014
from Market News Video
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here